PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in Ireland  by Mcgreal-bellone, A. et al.
tients with BC and B/BMM, which poses a significant burden in term of both cost
and mortality.
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INEQUALITIES AND AVOIDABLE COSTS OF IMAGING TEST IN THE DIAGNOSIS
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OBJECTIVES: To determine the variations and inequalities in accessing to diagnos-
tic imaging tests in patients with stroke. Others objectives are to determine the
degree of inadequate use of imaging and the subsequent avoidable costs at hospi-
tals in the Canary Islands. METHODS: Data on patients with a diagnosis of stroke
were extracted from hospital databases during the period 2005-2010. Trends in the
use of MRI and CT for the diagnosis and clinical management of stroke in recent
years were analyzed. Inequalities in access to imaging tests were analyzed by using
logistic regression models. The information was classified according to their sci-
entific evidence in “adequate” or “inadequate”. Whenever imaging tests were clas-
sified as “inadequate”, avoidable costs were computed. RESULTS: A higher Charl-
son comorbidity index and younger age increase the chance of receiving an MRI in
patients with stroke. In addition, results show a slight increment in the use of MRI
in recent years at four referral hospitals in the Canary Islands. We obtained a total
avoidable cost of 0.27%.CONCLUSIONS:Although the variations found in the use of
both tests are remarkable, only 0.3% of the total expenditure attributable to neu-
roimaging in patients with stroke could be avoided in a conservative scenario.
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EVALUATION OF TELEMEDICINE PROGRAM (ITHACA): INNOVATION IN THE
TREATMENT OF ARTERIAL HYPERTENSION INCREASING THE COMPLIANCE
AND ADHERENCE
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OBJECTIVES: To evaluate effectiveness of an interventional strategy (disease man-
agement program (DMP)) supported by a telemedicine platform in patients with
mild/moderate hypertension METHODS: Quasi-experimental design, paired data
with control group (1:2, patients were matched by age and gender). Study popula-
tion and follow-up period: patients from 6 primary care centers in Badalona (Bar-
celona, Spain) were followed-up during 2011. Study groups: intervention group
(telemedicine program) and control group (usual clinical practice). The interven-
tion consisted on establishing a permanent channel of interaction with the patient
(telemedicine platform) and providing the patient with educational materials, clin-
ical monitoring, SMS, phone calls, etc. Main measures: Demographic, co-morbidity,
anthropometric and biochemical parameters, adherence to treatment, blood pres-
sure control (BP: 140/90 mmHg), associated health care management costs and
satisfaction surveys to professionals and patients. Statistical significance:p0.05.
RESULTS: A total of 750 patients were included (intervention group n250, control
group n500). Mean age was of 64.2 years old 52.1% of patients were women. The
control group was selected to show an optimal comparability in terms of demo-
graphic and morbidity measures between the two groups. The intervention group
showed better compliance (87.9% vs. 71.4%, p0.001). BP control was 52.5 vs. 53.1%
(pNS) initially and 63.2% vs. 55.6% at the end of the study (p0.001) for the inter-
vention group vs. control, respectively. The follow-up average cost per patient and
year was € 377.9 vs. € 442.4, p0.001 (reduction in intervention group: 66 €). 82% of
health care professionals and 91% of patients were satisfied with the DMP.
CONCLUSIONS:The DMP has improved adherence to treatment and BP control and
has reduced health care management costs. If the study results were extrapolated
to the overall population of Badalona, a potential saving of 1.7 million per year
would be achieved.
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COMPARING PREDICTORS OF SELF-REPORTED ADHERENCE TO
MAMMOGRAPHY SCREENING GUIDELINES IN APPALACHIAN WOMEN WHO
UTILIZE MOBILE AND STATIONARY FACILITIES
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OBJECTIVES: To compare the characteristics of Appalachian women age 40 years
and above who utilized a mobile mammography unit to get a mammogram with
those who obtained mammography screening at a stationary facility, and to com-
pare the predictors of self-reported adherence in these samples. METHODS: Data
from 1,161 women who participated in the Bonnie Wells Wilson Mobile Mammog-
raphy Program and 1,104 women who utilized Betty Puskar Breast Care Center at
least once in the past ten years and completed a six-page Mammography Screening
and Preventive Care Survey were analyzed using the Andersen Behavioral Model to
determine the predictors of self-reported adherence to mammography screening
guidelines in these samples. RESULTS: A total of 48.2% of women who utilized the
mobile unit and 92.3% of women who utilized the stationary facility reported hav-
ing had a mammogram in the past two years consistent with current mammogra-
phy screening guidelines. Women who utilized the stationary facility had greater
proportion of women with higher levels of education, higher income, health insur-
ance, and following preventive behaviors such as clinical breast exam (CBE), Pap
test, and other screenings as compared to those who utilized the mobile unit. In
women who utilized the mobile unit, older age, being unemployed, being obese,
having a family history of BC, having had breast biopsy in the past and having had
a Pap test were significant predictors of self-reported adherence. In women who
utilized a stationary facility, being overweight, having health insurance, being ad-
herent to CBE and Pap test, and having positive views about mammography
screening were the significant predictors of self-reported adherence.
CONCLUSIONS: Women who utilized mobile unit had substantially lower adher-
ence to mammography screening than those who utilized the stationary facility.
Personal and/or community-based educational interventions need to be developed
around mobile mammography unit to increase mammography adherence in the
poor and underserved women.
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OBJECTIVES: To assess the change of health-related quality of life as an effect of
occupational therapy in community-dwelling dependent elderly. METHODS: In a
randomized control trial (RCT) we compared the effectiveness of occupational
therapy in community-dwelling dependent elderly. A total of 230 participants aged
65-95 were randomly assigned to either an occupational therapy group that per-
form exercises according to their meaningful activities ,or usual exercise group.
The intervention program was a 1h session two or three times per week. We eval-
uated all participants on activity of daily living (Barthel Index, BI) and health-
related quality of life (Health Utilities Index Mark3; HUI3). Measurements were
performed at baseline and after one month. RESULTS: Using linear mixed models,
the occupational therapy group were improved their mean HUI3 score at one
month from baseline (P  .001) (the occupational therapy group: 0.090.18; the
usual exercise group: 0.000.15). There was a significant group-by-time interaction
(P  .001) with the occupational therapy group showing a greater improvement
than the usual exercise group. However there was not a significant group-by-time
interaction (P0.051) by BI scores. CONCLUSIONS: Occupational therapy had ben-
eficial effects on health-related quality of life in community-dwelling dependent
elderly. The greatest effects were achieved through inclusion of a client-centered
meaningful activity program.
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HEPATITIS C INFECTION; USE OF THE 5-LEVEL EQ-5D QUESTIONNAIRE
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OBJECTIVES:Hepatitis C (HCV) is a major public health problem which is estimated
to affect up to 30,000 people in the Republic of Ireland. There is little information
regarding demographics or health-state utilities in this population in Ireland. We
aimed to establish demographics and health-state utilities among patients with
chronic HCV and differing degrees of liver disease.METHODS:A convenience sam-
ple of 200 patients with a current or past diagnosis of HCV, attending a specialist
Hepatology outpatient service was recruited. Informed consent was obtained from
all patients recruited and the study was approved by the institutional ethics review
board. Information was collected on demographic and clinical parameters and
patients were asked to complete the 5-level EQ-5D health-related quality of life
(HRQL) questionnaire. Continuous variables were summarized with medians and
standard deviations and compared using Students t-test. Categorical variables
were summarized with proportions. P-values 0.05 were taken to indicate
significance. RESULTS:A total of 134 (66%) were male; 149 (74%) were of Irish origin.
The majority were single (n90, 44%) and 117 (58%) were in either full-time or
part-time employment. The median age was 40 years (range 24-76 years) and the
mean years spent in full-time education was 11 years (range 1-25). Median health-
state utility was 0.73 (/0.23). For patients with chronic HCV infection, health
state utilities were as follows: Mild HCV 0.77 (/ 0.19), Moderate HCV 0.74 (/
0.23), Cirrhosis 0.60 (/ 0.35). Patients who had received treatment for HCV had a
higher mean utility score than patients who were never treated (0.8 versus 0.69,
p0.002). Patients with cirrhosis had significantly lower mean utility scores than
those without (0.60 versus 0.75, p0.001). CONCLUSIONS: HCV adversely affects
HRQL especially in those with cirrhosis.HCV treatment results in improved HRQL
regardless of treatment outcome. This supports HCV treatment prior to the devel-
opment of end-stage liver disease.
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OBJECTIVES: Hepatitis C (HCV) is a major cause of liver disease and can lead to
serious illness especially when co-infection with HIV occurs. With the develop-
ment of new agents to treat HCV, Health-related quality-of-life (HRQL) utilities in
co-infected patients will be of use in assessing the cost-effectiveness of these treat-
ments. The objective of this study is to establish standardized quality of life utility
values for patients with chronic HCV and HIV in Ireland who have different degrees
of liver disease.METHODS:A convenience sample of 41 patients with a diagnosis of
HCV/HIV co-infection attending a specialist HIV/HCV co-infection outpatient ser-
vice was recruited. Informed consent was obtained from all patients recruited and
the study was approved by the institutional ethics review board. Information was
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collected on demographic and clinical parameters and patients were asked to com-
plete the 5-level EQ-5D health-related quality of life (HRQL) questionnaire. Contin-
uous variables were summarized with medians and standard deviations and com-
pared using Students t-test. Categorical variables were summarized with
proportions. P-values 0.05 were taken to indicate significance. Data analyzed
using SPSS-19. RESULTS: There were 31 (76%) males. 38 (93%) had contracted HCV
through intravenous drug use. Median HRQL utility was 0.71 (/ 0.32). Mean HRQL
utilities were significantly lower in patients with cirrhosis (0.38 versus 0.67, p
0.03) and in patients with CD4 counts200 (0.41 versus 0.70, p0.005). Mean HRQL
scores were found to be higher in patients who had received HCV treatment than
those who did not (0.71 versus 0.52 ) although this did not reach statistical signifi-
cance (p 0.06). CONCLUSIONS: HRQL was found to be reduced in patients with
advanced HIV and HCV. Since HCV evolution to cirrhosis has been shown to reduce
quality of life, the importance of treatment of both HIV and HCV infection to pre-
vent progression of liver disease is emphasized.
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OBJECTIVES: Understand physician and patient perspectives with respect to pa-
tient involvement in treatment decisions and the perceived impact on patient
outcomes in SLE. METHODS: This was a cross-sectional U.S survey of independent
(geographically diverse) samples of practicing rheumatologists (with 3yrs of SLE
experience) and adult SLE patients recruited from panels & clinics. Study partici-
pants completed a one-time web-survey covering perceptions of SLE-manage-
ment, patient-physician-communication and expectations. Analysis included de-
scriptive statistics and subgroup comparisons using chi-square and t-tests.
RESULTS: 218 physicians (Caucasian 68%; African-American 1%; mean age 49ys)
and 166 patients (Caucasian 61%; African-American 30%; mean-age 47ys) com-
pleted the survey as of April 2012. Overall, 61% and 76% of physicians and patients,
respectively, reported high-patient-involvement (often/very often) in treatment
decisions. Physicians and patients in high-patient-involvement groups (vs. low-
patient-involvement groups): a) reported greater satisfaction with physician-pa-
tient interactions (physicians: 8.1vs.7.5,p0.12; patients: 9.1vs.6.3,p0.001) and b)
were more likely to discuss daily impacts all/most of the time (physicians:
70%vs.54%,p0.002; patients:76%vs.55%,p0.002). Among physicians, no differ-
ences were observed between high-vs.-low-patient-involvement groups in being
hopeful about patient future (95%vs.95%) and ratings of their bedside manner
(78%vs.75% warm/very-warm); whereas, among patients in high-vs.-low-involve-
ment groups, these ratings were 82%vs.67% (p0.001) and 72%vs.41% (p0.001),
respectively. More patients in high-involvement group reported not missing a
dose/appointment since treatment-initiation (59%vs.50%,p0.36) and setting clear
goals with their physicians (78%vs.26%,p0.003); more high-involvement patients
also reported their SLE had a high/very-high impact on their QOL (66%vs.53%,p
0.01). Those who believe that patient involvement in treatment decisions im-
proves outcomes ‘a lot’ differed significantly (p0.03) in high-vs.-low-patient-in-
volvement groups among physicians (57%vs.0%) and patients (58%vs.35%).
CONCLUSIONS:Rheumatologists and SLE-patients reporting high-patient-involve-
ment in treatment related decisions were relatively more satisfied with their inter-
actions and had a positive outlook on future and outcomes. Further research is
warranted to assess factors influencing these attitudes and their impact on patient
outcomes in clinical practice.
PHS62
ASSESSMENT OF PATIENT SATISFACTION WITH CHRONIC TREATMENT USING
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Bakhai A1, Greiner W2, Mittendorf T3, Berto P4, Campbell D5, Sandberg A6, Oberdiek A7,
Zamorano JL8
1Barnet and Chase Farm Hospitals NHS Trust, London, UK, 2Universität Bielefeld, Bielefeld,
Germany, 3Herescon GmbH, Hannover, Germany, 4University of Padova and Analytica Laser,
Verona, Italy, 5Oxford PharmaGenesis, Oxford, Oxford, UK, 6Daiichi Sankyo Europe GmbH,
Munich, Germany, 7Daiichi Sankyo Europe, Munich, Germany, 8Hospital Ramón y Cajal, Madrid,
Spain
OBJECTIVES: Lifelong treatment for many chronic conditions, such as atrial fibril-
lation (AF), involves complex care pathways with numerous points of interaction
between patients and health care providers. The EUPS-AF was conducted to assess
patient-reported levels of satisfaction with current management of AF in Europe.
METHODS: The EUPS-AF questionnaire was adapted from the 2008 Common-
wealth Fund International Health Policy Survey of Chronically Ill Adults by includ-
ing additional questions capturing AF-specific patient characteristics and treat-
ment preferences. Computer-assisted telephone interviews were conducted
between February and July 2011 via randomized digital dialling covering the entire
adult populations of France, Germany, Italy, Spain and the UK. Questions covered
the following nine domains: overview of the health system; ease of health care
access; relationship with care providers; hospital experience; use of medication,
coordination of polymedication and cost; safety concerns; experience with other
chronic diseases; access to information; financial burden. RESULTS: Of the 340,476
individuals contacted, 1.08% were identified with AF; 1793 were eligible for inclu-
sion after screening; 321 (17.6%) declined to participate. Interviews were conducted
in 1507 adults (50% women); mean age 70 years. On average, 43% lived in a village
or rural location. Mean number of people per household was two; 56% had an
income below average; 54% had been hospitalized during the past 2 years, with an
average of 2.2 comorbidities and 5.7 prescription medications. Overall satisfaction
rates ranged from 37% (Italy) to 55% (UK). CONCLUSIONS: The EUPS-AF, under-
taken uniquely from a patient perspective before the introduction of novel oral
anticoagulants into clinical practice, provides additional and complementary data
to clinical trials and registries and allows the detection of international variations
in satisfaction levels of patients with AF. This can promote research into the causes
of variation, focus where innovations may be beneficial, and may reduce inequal-
ities in standards of care if these underlie the variations.
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PATIENT PERCEPTION OF AN ORAL SYSTEMIC ANTI-CANCER THERAPY
HOMECARE SERVICE
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Surrey, West Sussex and Hampshire Cancer Network, Guilford, Surrey, UK
OBJECTIVES: Evaluate from the patient perspective a systemic anti-cancer therapy
homecare service METHODS: A pilot project was undertaken at the Royal Surrey
County Hospital, in England, where three oral anti-cancer drugs were prescribed by
hospital clinicians but dispensed by a homecare company. Patients were asked at
the point of recruitment by the oncology pharmacists at the Royal Surrey County
Hospital whether they were willing to take part in the homecare project. A ques-
tionnaire was developed with the input of patients. The questionnaire was tested
with five patients for acceptability and their comments fed into the design of the
final questionnaire. The questionnaire consisted of open and closed questions and
was sent out by the homecare company to all patients who were receiving home-
care six months after the start of the project. The questionnaire was returned to the
Cancer Network Pharmacist for analysis. RESULTS: Ninety-one patients were ap-
proached to take part in the project by the oncology pharmacy staff at the Royal
Surrey County Hospital. When first approached 78 patients were prepared to take
part in project, some declined and others required time to decide. The question-
naire was sent out to 85 patients. A total of 49 questionnaires were returned but
some were not included in the analysis as they were from deceased patients or had
been completed by a carer. Of the 40 questionnaires analysed 34 patients were
willing to continue to receive their medication via homecare, 18 specifically stated
a benefit was not waiting at the hospital for their medicine and 4 patients specifi-
cally stated they preferred to receive their medicines via homecare than from a
community pharmacy. CONCLUSIONS: Patients find homecare acceptable for the
delivery of systemic anti-cancer therapy and some prefer it to waiting at hospital
for their medication or going to a community pharmacy to have their prescription
dispensed.
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OBJECTIVES: To analyze the willingness for shared decision making (SDM) of rheu-
matologic patients. METHODS: All rheumatic patients assisted were invited to
participate in this cross-sectional study. A three parts questionnaire was applied
(demographic, clinical data and 3 scenarios that simulate a clinical encounter). The
scenarios presented the 3 typical steps of a consultation, according to SDM process:
1) Diagnostic statement; 2) treatment options discussion; 3) decision-making. For
each step, interviewee was argued 3 questions: a) To identify weather each part
was similar to his/her clinical encounter or not; b) to define whether SDM can be a
feasible approach; and c) to answer if he/she wanted to be assisted in SDM process,
justifying it. Descriptive and multiple correspondence analysis (MCA) techniques
were performed to explore data.RESULTS:Demographic data (N160): 89% female,
60%  8 years of school, 48.8% had  4 years of diagnosis and 30%,  8 years of
diagnosis. Scenario one: 97% would like to have SDM approach on their real clinical
practice, justified according to ‘communication empowerment’ (75%) and ‘pa-
tients’ right relationship’ (23%). Scenario two: 65% declared that they like SDM
purpose, justifying it according to ‘communication empowerment’ (63%)’. Scenario
three: 65% of the participants never took part in the decision process. However, 98%
would like to do it, justifying according to ‘patients’ right relationship’ (30%), and
‘communication empowerment’ (28%) but 13% answered that the whole decision
belongs to the physician. MCA plot illustrates that for diagnostic statement ‘com-
munication empowerment’ correlates to low literacy. To understand treatment
option, communication empowerment and patient’s right was correlated with
those who had  4 years of diagnosis; and  two rheumatic conditions.
CONCLUSIONS: Communication empowerment and patient’s right were the most
common reasons for the willingness for SDM.
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MAPPING THE DISEASE-SPECIFIC FACT-P TO THE PREFERENCE-BASED EQ-5D IN
CASTRATION-RESISTANT PROSTATE CANCER
Ivanescu C1, Skaltsa K2, Holmstrom S3
1Quintiles, Hoofddorp, The Netherlands, 2Bioclever, Barcelona, Spain, 3Astellas Pharma Global
Development, Leiderdorp, The Netherlands
OBJECTIVES: To develop a mapping algorithm for converting the prostate cancer
specific Health-Related Quality of Life (HRQoL) instrument FACT-P (Functional As-
sessment of Cancer Therapy–Prostate) to the preference-based EQ-5D (Euro-QoL
5D) instrument for measuring health status. METHODS: Data were obtained from
the phase 3 placebo-controlled AFFIRM trial of enzalutamide-proposed INN
(MDV3100) in men with metastatic castration-resistant prostate cancer previously
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